CCM
Concord Medical Services Holdings Limited
NYSE · Healthcare · Medical - Care Facilities · CN
$4.68
+5.05%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 585.7M | 460.5M | 384.0M | 537.4M | 472.1M |
| Cost of Revenue | 545.3M | 434.7M | 463.1M | 614.0M | 624.5M |
| Gross Profit | 40.3M | 25.8M | (79.2M) | (76.6M) | (152.4M) |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 325.2M | 265.2M | 453.0M | 386.4M | 372.6M |
| General & Admin Expense | 166.2M | 213.0M | 404.4M | 330.1M | 311.2M |
| Selling & Marketing Expense | 36.6M | 52.2M | 48.6M | 56.3M | 61.5M |
| Other Expenses | 11.1M | — | — | — | — |
| Total Operating Expenses | 336.3M | 265.2M | 453.0M | 386.4M | 372.6M |
| Cost and Expenses | 881.7M | 699.8M | 916.1M | 1.0B | 997.1M |
| Operating Income (EBIT) | (239.3M) | (239.3M) | (532.2M) | (463.0M) | (525.0M) |
| Non-Operating | |||||
| Interest Income | 5.0M | 9.7M | 14.0M | 10.8M | 10.0M |
| Interest Expense | 152.3M | 152.3M | 193.2M | 165.7M | 120.4M |
| Net Interest Income | (142.6M) | (142.6M) | (179.2M) | (154.8M) | (110.3M) |
| Other Non-Op Income/Expense | (134.0M) | (134.0M) | (137.4M) | (92.6M) | (314.8M) |
| Non-Operating Income (excl Interest) | (11.1M) | — | (55.8M) | — | — |
| EBT (Pre-Tax Income) | (373.4M) | (373.4M) | (669.6M) | (555.6M) | (839.9M) |
| Income Tax Expense | 6.1M | 6.1M | (17.5M) | (24.6M) | (70.9M) |
| Bottom Line | |||||
| Net Income | (124.4M) | (92.8M) | (308.2M) | (297.7M) | (489.7M) |
| Earnings from Cont. Ops | (379.4M) | (379.4M) | (652.1M) | (531.0M) | (769.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (124.4M) | (90.3M) | (308.2M) | (297.7M) | (489.7M) |
| Per Share | |||||
| Basic EPS | ($856.80) | ($621.00) | ($2,116.80) | ($2,044.20) | ($3,362.70) |
| Diluted EPS | ($859.20) | ($621.00) | ($2,116.80) | ($2,044.20) | ($3,362.70) |
| Revenue Per Share | $4,046.75 | $3,162.54 | $2,637.06 | $3,690.95 | $3,242.34 |
| Shares | |||||
| Basic Shares Outstanding | 144724 | 145615 | 145600 | 145600 | 145600 |
| Diluted Shares Outstanding | 144724 | 145615 | 145600 | 145600 | 145600 |
| Profitability Metrics | |||||
| EBITDA | (121.2M) | (71.8M) | (345.6M) | (344.2M) | (401.9M) |
| D&A | 163.7M | 149.3M | 130.8M | 118.8M | 123.2M |
| EBIT | (284.9M) | (221.0M) | (476.4M) | (463.0M) | (525.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025